SCIEX and New Objective Partner
News May 26, 2015
SCIEX has announced a partnership with an industry leader in innovative nanospray technology, New Objective, Inc. that will enable SCIEX to offer the New Objective Digital PicoView® 450 Source for use with the latest generation SCIEX mass spectrometry systems. These high performance nanospray ionization sources offer maximum sensitivity for researchers working with precious samples, and are particularly suitable for proteomics researchers using the SCIEX TripleTOF® 6600 Next-Generation Proteomics System.
Nanospray ion sources are widely used for high sensitivity LC-MS applications, supporting researchers needing to analyze limited amounts of biological samples. Challenges in qualitative and quantitative analysis demand high performance in long-term robustness and spray stability. The New Objective Digital PicoView 450 is a digitally controlled, flexible and reliable nanospray source that provides consistent high performance and meaningful results, allowing researchers to spend less time benchmarking and, instead, reach scientific answers more quickly.
Reid Townsend, M.D., Ph.D., Professor of Medicine and Director, Mass Spectrometry Resource at Washington University, St. Louis, has been testing the Digital PicoView 450 Source. He commented, "We have used New Objective PicoView nano-sources for over a decade and Digital PicoView sources for 7 years. We have found them suitable for 24/7 operation for 2-3 week blocks of continuous LC-MS analysis. Ease of spray visualization is an impressive feature. This (Digital PicoView) is the most stable, robust nanospray set-up I've ever had".
"By bringing together these two leading companies in mass spectrometry and nanospray technology we will continue to provide the most advanced workflows in life science research; SCIEX is very proud to be a part of this," said Aaron Hudson, Senior Director of Academic and Clinical Research Business of SCIEX.
"At New Objective we build strong customer relationships scientist-to-scientist and strive to provide innovative, enabling solutions," said Gary Valaskovic, Ph.D., President and co-founder of New Objective. "Partnering with SCIEX is a great opportunity for us to forge new relationships through their market leading position in quantitative analysis."
This partnership is the latest in SCIEX’s continuous commitment to provide life science researchers with innovative solutions to further their Omics research.
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.